← Back to Search

Advanced Imaging Techniques for Breast Cancer

N/A
Waitlist Available
Led By Abass Alavi, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women recently diagnosed with Breast Cancer
Be older than 18 years old
Must not have
Previously diagnosed with breast cancer (in the same breast) within the past 5 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is investigating whether four different state-of-the-art breast imaging techniques are better than each other at diagnosing breast cancer, and whether they work better together than alone.

Who is the study for?
This trial is for women recently diagnosed with breast cancer who will have surgery at the Hospital of the University of Pennsylvania. It's not for pregnant women, those treated with preoperative therapy for advanced cancer, anyone with MRI contraindications, or a past diagnosis in the same breast within 5 years.
What is being tested?
The study compares four imaging techniques—MRI, digital mammography (DMAM), ultrasound, and PET scans—to see how well they work together to determine the extent of breast cancer before surgery.
What are the potential side effects?
Potential side effects may include discomfort during procedures, exposure to radiation from DMAM and PET scans which carries a small risk of harmful effects, and possible allergic reactions to contrast materials used in MRI and PET.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been recently diagnosed with breast cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I was diagnosed with breast cancer in the same breast within the last 5 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients Diagnosed with Breast CancerExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,084 Previous Clinical Trials
42,726,648 Total Patients Enrolled
27 Trials studying Breast Cancer
25,970 Patients Enrolled for Breast Cancer
Abass Alavi, MDPrincipal InvestigatorUniversity of Pennsylvania
3 Previous Clinical Trials
777 Total Patients Enrolled

Media Library

MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET) Clinical Trial Eligibility Overview. Trial Name: NCT00367666 — N/A
~3 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top